Skip to Content

ACCESS

GLIDESHEATH® SLENDER Tibial Pedal Kit

Use With Confidence

  • Only 0.021” wire on market and provides: greater rail strength to prevent buckling through scarred or calcified arteries1

Increase Efficiency

  • The Glidesheath Slender Tibial Pedal needle technology requires less penetration force compared to competitive needle1

Reduce Complications

  • Designed to minimize mechanical irritation to the artery1


Advance Your Approach to Tibial Pedal Access

Expand your options for procedural success with the proprietary technology of GLIDESHEATH SLENDER, designed for tibial pedal access.
 

Access with Detailed and Sophisticated Design

Needle Size Comparison

4 cm

7cm

Note: Needle diagram not to scale.

Additional Resources

GLIDESHEATH SLENDER® Tibial Pedal Kit* includes:

CODE SHEATH DILATOR MINI-GUIDEWIRE NEEDLE NEEDLE LENGTH
52-1050 5 Fr 10 cm 0.021" Nitinol/Floppy
0.021" x 43 cm
21G-19G (Tapered)
Echogenic
4 cm (40 mm)
51-1050 5 Fr 10 cm 0.021" Nitinol/Floppy
0.021" x 43 cm
21G-19G (Tapered)
Echogenic
7 cm (70 mm)

*5 per Shelf Box | Sheath Length: 10 cm | Wire Length: 43 cm | 4 cm or 7 cm Needle


What French sheath sizes are appropriate for tibial-pedal access in endovascular procedures, and how do pedal access kits impact outcomes?

Tibial-pedal access is critical in endovascular treatment of critical limb-threatening ischemia (CLTI), particularly when antegrade femoral access is limited. Given the small caliber of distal arteries (2–3 mm), 4 Fr and 5 Fr sheaths are most commonly used. 4 Fr sheaths are generally preferred due to their low outer diameter (~1.33 mm), which reduces the risk of arterial injury, spasm, and occlusion.1

Dedicated pedal access kits are designed to minimize trauma and improve procedural safety. Clinical studies, including the LIFE-BTK trial, support the use of low-profile access systems to improve technical success and reduce site-related complications.2

Related Products

References

RX ONLY. Refer to the product labels and package insert for complete warnings, precautions, potential complications, and instructions for use.

  1. Data on file.
    1 Mustapha, J. A. et al. (2019). J Endovasc Ther, 26(4), 524–532.
    2 Conte, M. S. et al. (2022). J Vasc Surg, 76(1), 101–112.